Anti-Adhesion Products: Market Research Report
This report analyzes the worldwide markets for Anti-Adhesion Products in US$ Million the report is broadly classified into three major end-use segments: General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Surgical Procedures. The report provides separate comprehensive analytics for US, Europe, and Rest of World. Annual forecasts are provided for each region for the period 2006 through 2015. The report profiles 20 companies including many key and niche players worldwide such as Angiotech Pharmaceuticals, Inc., Anika Therapeutics, Inc., Baxter International, Inc., Genzyme Corporation, Covidien, Fidia Farmaceutici, S.P.A, FzioMed, Inc., Integra LifeSciences Corporation, LifeCell Corporation, MAST Biosurgery AG, and Synthemed, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
Contents
I.INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONStudy Reliability and Reporting Limitations
Disclaimers
Data Interpretation & Reporting Level
Quantitative Techniques & Analytics
Product Definitions and Scope of Study
Adhesion
Anti-Adhesion Products
Market Segmentation
General/Abdominal Surgery
Pelvic/Gynecological Surgery
Other Surgical Procedures
II. EXECUTIVE SUMMARY
1.MARKET OVERVIEW
Global Market for Anti-Adhesion Products – Fast Facts
Market Snapshots
Incidence of Adhesions– A Quick Note
Table 1: World Market for Anti-Adhesion Products: Percentage Share of Surgical Procedures that Require Adhesion Prevention Products by Geographic Region (includes corresponding Graph/Chart)
Table 2: Worldwide Incidence of Post Surgical Adhesions by Surgical Procedure (2009E)
Market Dynamics
New Products to Intensify Sales and Competition
Products in Pipeline
World Anti-Adhesion Products Market- Pipeline Products Under Development, 2009
Growth Restraints
2.PRODUCT OVERVIEW
Adhesion
Mechanism of Adhesion Formation
Causes of Adhesions
Related Complications
Symptoms of Adhesion
Preventive Techniques
Anti-Adhesion Products
Market Segmentation
General/Abdominal Surgery
Pelvic/Gynecological Surgery
Other Surgical Procedures
Review of Select Anti-Adhesion Products Available
3.RECENT INDUSTRY ACTIVITY
PharmaSurgics Completes Phase I Study for PXL01
Angiotech Pharmaceuticals and Baxter International Sign License and Distribution Agreement
SyntheMed Receives FDA Approval for PMA Application of REPEL-CV Adhesion Barrier for Use in Pediatric Surgery
SyntheMed Receives FDA Approval for Sinus Shield
Covidien Introduces Sprayshield ™ in Europe
4.FOCUS ON SELECT PLAYERS
Angiotech Pharmaceuticals, Inc. (Canada)
Anika Therapeutics, Inc (US)
Baxter International, Inc. (US)
Genzyme Corporation (US)
Covidien (Ireland)
Fidia Farmaceutici, S.P.A (Italy)
FzioMed, Inc. (US)
Integra LifeSciences Corporation (US)
LifeCell Corporation (US)
MAST Biosurgery AG (Switzerland)
Synthemed, Inc. (US)
5.GLOBAL MARKET PERSPECTIVE
Table 3: World Recent Past, Current & Future Analysis for Anti-Adhesion Products by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 4: World 10-Year Perspective for Anti-Adhesion Products by Geographic Region – Percentage Breakdown of Annual Revenues for US, Europe, and Rest of World Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart)
Table 5: World Recent Past, Current & Future Analysis for Anti-Adhesion Products in General/Abdominal Surgery by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 6: World 10-Year Perspective for Anti-Adhesion Products in General/Abdominal Surgery by Geographic Region – Percentage Breakdown of Annual Revenues for US, Europe, and Rest of World Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart)
Table 7: World Recent Past, Current & Future Analysis for Anti-Adhesion Products in Pelvic/Gynecological Surgery by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 8: World 10-Year Perspective for Anti-Adhesion Products in Pelvic/Gynecological Surgery by Geographic Region – Percentage Breakdown of Annual Revenues for US, Europe, and Rest of World Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart) (includes corresponding Graph/Chart)
Table 9: World Recent Past, Current & Future Analysis for Anti-Adhesion Products in Other Surgical Procedures by Geographic Region – US, Europe, and Rest of World Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 10: World 10-Year Perspective for Anti-Adhesion Products in Other Surgical Procedures by Geographic Region – Percentage Breakdown of Annual Revenues for US, Europe, and Rest of World Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart)
III. MARKET
1.THE UNITED STATES
A. Market Analysis
Overview
Growth Drivers
Competition
Table 11: Leading Players in the US Anti-Adhesion Products Market: Percentage Breakdown of Sales for Genzyme, Ethicon, and Others (includes corresponding Graph/Chart)
Products in Pipeline
Ant-Adhesion Products Market in the US: Pipeline Products Under Development, 2009
Strategic Corporate Developments
Key Players
B. Market Analytics
Table 12: US Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 13: US 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
2.EUROPE
A. Market Analysis
Competition
Table 14: Leading Players in European Anti-Adhesion Products Market: Percentage Breakdown of Sales for Genzyme, Ethicon, and Others (includes corresponding Graph/Chart)
Strategic Corporate Development
Key Players
B. Market Analytics
Table 15: European Recent Past, Current & Future Analysis for Anti-Adhesion Products by Geographic Region – France, Germany, Italy, UK, Spain and Rest of Europe Markets Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 16: European 10-Year Perspective for Anti-Adhesion Products by Geographic Region – Percentage Breakdown of Annual Revenues for France, Germany, Italy, UK, Spain and Rest of Europe Markets for Years 2006, 2009 & 2015 (includes corresponding Graph/Chart)
Table 17: European Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/ Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 18: European 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
2a.FRANCE
Market Analysis
Table 19: French Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/ Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 20: French 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
2b.GERMANY
Market Analysis
Table 21: German Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/ Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 22: German 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
2c.ITALY
Market Analysis
Table 23: Italian Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/ Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 24: Italian 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/ Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
2d.UNITED KINGDOM
Market Analysis
Table 25: UK Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/ Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 26: UK 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/ Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
2e.SPAIN
Market Analysis
Table 27: Spanish Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/ Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 28: Spanish 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/ Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
2f.REST OF EUROPE
A. Market Analysis
Strategic Corporate Development
B. Market Analytics
Table 29: Rest of Europe Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 30: Rest of Europe 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
3.REST OF WORLD
Market Analysis
Table 31: Rest of World Recent Past, Current & Future Analysis for Anti-Adhesion Products by Application Area – General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Others Independently Analyzed with Annual Revenue Figures in US$ Million for Years 2006 through 2015 (includes corresponding Graph/Chart)
Table 32: Rest of World 10-Year Perspective for Anti-Adhesion Products by Application Area– Percentage Breakdown of Annual Revenues for General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Other Markets for 2006, 2009 & 2015 (includes corresponding Graph/Chart)
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 20 (including Divisions/Subsidiaries - 28)
Region/CountryPlayers
The United States
Canada
Japan
Europe
Germany
The United Kingdom
Italy
Rest of Europe
Asia-Pacific (Excluding Japan)
Please read Global Industry Analysts, Inc., - Sales Policy below before placing an order:
All Publications from Global Industry Analysts, Inc., (GIA) are protected per protocols of the Universal Copyrights Convention and the United States Copyrights Office. It is GIA’s policy that once purchased, these publications may not be returned for any reason. GIA makes all reasonable attempts to report current and accurate information in its publications.
GIA will not be responsible for any type of damages (financial or other) incurred by the client (company or individual) in the usage of GIA’s publications or services. The client agrees that in case a legal resolution becomes necessary, the venue shall be the city of San Francisco, California, USA. Under any circumstances, GIA’s liability shall be limited to the exact price of the product or service paid to GIA by the client.
This publication is sold as a single-user single-site license. Electronic versions operate like normal PDF files once installed and permit unlimited print and cut & paste. Digital controls and watermarks are set on electronic copies and are protected against copying. Extra licenses can be purchased for the same location at 10% of the list price.